{"id":"low-intensity-statin-plus-ezetimibe","safety":{"commonSideEffects":[{"rate":null,"effect":"Muscle pain or myalgia"},{"rate":null,"effect":"Elevated liver enzymes"},{"rate":null,"effect":"Gastrointestinal upset"},{"rate":null,"effect":"Headache"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Low-intensity statins inhibit HMG-CoA reductase to decrease hepatic cholesterol production, while ezetimibe blocks the Niemann-Pick C1-like 1 (NPC1L1) transporter to reduce dietary and biliary cholesterol absorption in the intestine. Together, they provide complementary mechanisms to lower circulating LDL cholesterol levels more effectively than either agent alone at lower individual doses.","oneSentence":"A combination therapy that reduces LDL cholesterol through dual inhibition of cholesterol synthesis (statin) and intestinal cholesterol absorption (ezetimibe).","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:42:26.299Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypercholesterolemia and dyslipidemia management"},{"name":"Cardiovascular risk reduction in patients requiring LDL cholesterol lowering"}]},"trialDetails":[{"nctId":"NCT07359105","phase":"NA","title":"Moderate-intensity Statin vs. Individualized LDL-C Target-based Therapy in Older Adults With Type 2 Diabetes (iTARGET-Elderly Study)","status":"RECRUITING","sponsor":"Sin Gon Kim","startDate":"2026-03-09","conditions":"Dyslipidemia Associated With Type II Diabetes Mellitus","enrollment":2186},{"nctId":"NCT05579626","phase":"PHASE4","title":"Comparison of Low-Intensity Statin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus (PROVE-DM)","status":"ENROLLING_BY_INVITATION","sponsor":"Seung-Whan Lee, M.D., Ph.D.","startDate":"2023-03-14","conditions":"Pre Diabetes, ASCVD","enrollment":4000},{"nctId":"NCT05081336","phase":"","title":"Low-density Lipoprotein Cholesterol Reduction With State-of-the-art Therapy in Secondary Prevention and Major Cardiovascular Adverse Events: Republic of Srpska Registry","status":"UNKNOWN","sponsor":"University Clinical Centre of Republic of Srpska","startDate":"2021-03-01","conditions":"Acute Coronary Syndrome, Dyslipidemias","enrollment":500},{"nctId":"NCT03355027","phase":"NA","title":"Investigating the Lowest Threshold of Vascular Benefits From LDL Cholesterol Lowering in Patients With Stable CV Disease","status":"UNKNOWN","sponsor":"Cambridge University Hospitals NHS Foundation Trust","startDate":"2017-11-30","conditions":"Atherosclerosis, Cardiovascular Diseases","enrollment":60},{"nctId":"NCT03277079","phase":"PHASE4","title":"Low Dose Statins, Ezetimibe and Nutraceuticals","status":"UNKNOWN","sponsor":"University of Roma La Sapienza","startDate":"2017-10-01","conditions":"Coronary Artery Disease","enrollment":100}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"low-intensity statin plus ezetimibe","genericName":"low-intensity statin plus ezetimibe","companyName":"Seung-Whan Lee, M.D., Ph.D.","companyId":"seung-whan-lee-m-d-ph-d","modality":"Small molecule","firstApprovalDate":"","aiSummary":"A combination therapy that reduces LDL cholesterol through dual inhibition of cholesterol synthesis (statin) and intestinal cholesterol absorption (ezetimibe). Used for Hypercholesterolemia and dyslipidemia management, Cardiovascular risk reduction in patients requiring LDL cholesterol lowering.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}